| Paul Walker, MD | |
|
2801 Bay Park Dr, Oregon, OH 43616-4920 | |
| (419) 690-7900 | |
| Not Available |
| Full Name | Paul Walker |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 2801 Bay Park Dr, Oregon, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154313641 | NPI | - | NPPES |
| 000000246962 | Other | OH | ANTHEM |
| 4488350 | Medicaid | MI | |
| 0921551 | Medicaid | OH | |
| 000000550257 | Other | OH | ANTHEM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 35064490 (Ohio) | Primary |
| Entity Name | Emergency Physicians Of Northwest Ohio, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043274418 PECOS PAC ID: 3375456478 Enrollment ID: O20031106000006 |
News Archive
The top attorney for the state of Florida asked a federal appeals court today to reinstate a Florida law that regulates what physicians can ask patients about gun ownership, asserting that the law does not actually stifle such questions. Yes, it does, countered a lawyer representing several Florida medical societies and individual physicians who challenged the law as an infringement on their First Amendment right to free speech (Lowes, 7/18).
Callisto Pharmaceuticals has announced additional data confirming efficacy of Guanilib, a first-in-class compound currently being developed for the treatment of inflammatory bowel disease (IBD), in two different standard animal models of experimental colitis.
Iron oxide nanoparticles have shown promise as agents for detecting tumors using magnetic resonance imaging (MRI), but such efforts have been limited by the relatively weak magnetic signal generated by these nanoparticles.
Furiex Pharmaceuticals, Inc. and Menarini Group today announced that they have entered into a license agreement by which Furiex will license to Menarini rights to commercialize Priligy in Europe, most of Asia, Africa, Latin America and the Middle East.
› Verified 6 days ago
| Entity Name | Omni Health Services, Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932380086 PECOS PAC ID: 2961584610 Enrollment ID: O20080204000037 |
News Archive
The top attorney for the state of Florida asked a federal appeals court today to reinstate a Florida law that regulates what physicians can ask patients about gun ownership, asserting that the law does not actually stifle such questions. Yes, it does, countered a lawyer representing several Florida medical societies and individual physicians who challenged the law as an infringement on their First Amendment right to free speech (Lowes, 7/18).
Callisto Pharmaceuticals has announced additional data confirming efficacy of Guanilib, a first-in-class compound currently being developed for the treatment of inflammatory bowel disease (IBD), in two different standard animal models of experimental colitis.
Iron oxide nanoparticles have shown promise as agents for detecting tumors using magnetic resonance imaging (MRI), but such efforts have been limited by the relatively weak magnetic signal generated by these nanoparticles.
Furiex Pharmaceuticals, Inc. and Menarini Group today announced that they have entered into a license agreement by which Furiex will license to Menarini rights to commercialize Priligy in Europe, most of Asia, Africa, Latin America and the Middle East.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paul Walker, MD Po Box 633390, Cincinnati, OH 45263-3390 Ph: (800) 594-1876 | Paul Walker, MD 2801 Bay Park Dr, Oregon, OH 43616-4920 Ph: (419) 690-7900 |
News Archive
The top attorney for the state of Florida asked a federal appeals court today to reinstate a Florida law that regulates what physicians can ask patients about gun ownership, asserting that the law does not actually stifle such questions. Yes, it does, countered a lawyer representing several Florida medical societies and individual physicians who challenged the law as an infringement on their First Amendment right to free speech (Lowes, 7/18).
Callisto Pharmaceuticals has announced additional data confirming efficacy of Guanilib, a first-in-class compound currently being developed for the treatment of inflammatory bowel disease (IBD), in two different standard animal models of experimental colitis.
Iron oxide nanoparticles have shown promise as agents for detecting tumors using magnetic resonance imaging (MRI), but such efforts have been limited by the relatively weak magnetic signal generated by these nanoparticles.
Furiex Pharmaceuticals, Inc. and Menarini Group today announced that they have entered into a license agreement by which Furiex will license to Menarini rights to commercialize Priligy in Europe, most of Asia, Africa, Latin America and the Middle East.
› Verified 6 days ago
Mark Sniadanko, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2600 Navarre Ave, Oregon, OH 43616 Phone: 419-696-7500 | |
Erica Pribis, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2801 Bay Park Dr, Oregon, OH 43616 Phone: 419-690-7900 | |
Dr. Melissa K Amonette, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2600 Navarre Avenue, Oregon, OH 43616 Phone: 419-696-7300 | |
Josh Bohn, Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3225 Pickle Rd, Oregon, OH 43616 Phone: 419-693-0465 | |
Wendelin Kreifels, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2600 Navarre Ave, Oregon, OH 43616 Phone: 419-696-7411 | |
Lynn T Mason, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2600 Navarre Ave, Oregon, OH 43616 Phone: 419-696-7411 |